A Novel Circular Delta‐XBB.1.5 RBD Dimeric Protein Subunit Vaccine Mediated by Split Intein Elicits an Immune Response and Protection Against Multiple SARS‐CoV‐2 Variants in Mice

Documenti analoghi

• Oral Ad5 Vector‐Based SARS‐CoV‐2 Vaccine Effectively Induces Mucosal and Systemic Immune Responses in BALB/c Mice
  di: Tongyao Mao, et al.
  Pubblicazione: (2025)
• Antibody and B‐Cell Responses to PHH‐1V81 XBB.1.16‐Adapted SARS‐CoV‐2 Booster Vaccination Are Associated With Variant Neutralization
  di: Cèlia Torres, et al.
  Pubblicazione: (2025)
• Dynamics of Crossed Acquired Immunity Against SARS‐CoV‐2 Variants: From Vaccine to Hybrid Immunity in China
  di: Hao Wang, et al.
  Pubblicazione: (2025)
• Discovery of a Novel Public Antibody Lineage Correlated With Inactivated SARS‐CoV‐2 Vaccine and the Resultant Neutralization Activity
  di: Jing Wang, et al.
  Pubblicazione: (2024)
• Maternal Vaccination and Protective Immunity Against SARS‐CoV‐2 Infection in Pups
  di: Kunpeng Liu, et al.
  Pubblicazione: (2025)